Cardiac glycosides and COVID-19: would it be a promising therapeutic approach?
Abstract Cardiac glycosides have been found to have an anti-viral effect. This was noted in the past during various epidemics including MERS and SARS. It is due to their inhibitory effect on the Na, K-ATPase membrane pump. Furthermore, they exhibit anti-inflammatory properties. These preclinical obs...
Main Authors: | EFTYCHIOS SINIORAKIS, SPYRIDON ARVANITAKIS, MAXIMILIANOS ELKOURIS |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Ciências
2020-10-01
|
Series: | Anais da Academia Brasileira de Ciências |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652020000700203&tlng=en |
Similar Items
-
COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure
by: Eftychios Siniorakis, et al.
Published: (2020-06-01) -
Anticancer and Antiviral Properties of Cardiac Glycosides: A Review to Explore the Mechanism of Actions
by: Dhanasekhar Reddy, et al.
Published: (2020-08-01) -
When sacubitril/valsartan met neprilysin and B-type natriuretic peptide in the labyrinth of biochemistry
by: Eftychios Siniorakis, et al.
Published: (2020-03-01) -
Studies of the clinical pharmacology of cardiac glycosides
by: Aronson, J
Published: (1977) -
Anticancer and Immunogenic Properties of Cardiac Glycosides
by: Naira Fernanda Zanchett Schneider, et al.
Published: (2017-11-01)